Recently I am researching about CAMBRIDGE STRUCTURAL DATABASE; PHARMACEUTICAL COCRYSTALS; INTERMOLECULAR INTERACTIONS; SOLUBILITY, Saw an article supported by the Boehringer IngelheimBoehringer Ingelheim [227100]. Published in ROYAL SOC CHEMISTRY in CAMBRIDGE ,Authors: Sarkar, N; Sinha, AS; Aakeroy, CB. The CAS is 385-00-2. Through research, I have a further understanding and discovery of 2,6-Difluorobenzoic acid. COA of Formula: C7H4F2O2
Co-crystallizations can be utilized for generating new solid forms of a target substance in order to alter or enhance some specific bulk physical property. Generally, selection of the co-former (the necessary partner for the target molecule) is based on existing structural information about molecular recognition events involving complementary functional groups, and extensive experimental screening methods. In this study, we utilize structure-informatics in an attempt to predict if two different molecules will form a co-crystal or not. Our study is based on hydrogen-bond propensity (HBP), and the key premise of our approach rests on whether target-co-former interactions are more likely to take place than either target-target or co-formerco-former hydrogen bonds. We examined six different target molecules in combination with 25 possible co-formers each and used the HBP protocol for predicting if a co-crystal would form or not. The predictions were then compared with results from an experimental co-crystal screen of the 150 different combinations. The correct outcome was successfully predicted 92-95% of the time which shows that for this series of small molecules, HBP is a very reliable indicator for determining if a co-crystal will form between a target molecule and a particular co-former.
COA of Formula: C7H4F2O2. About 2,6-Difluorobenzoic acid, If you have any questions, you can contact Sarkar, N; Sinha, AS; Aakeroy, CB or concate me.
Reference:
Isothiazole – Wikipedia,
,Isothiazole – ScienceDirect.com